Issue link: https://www.e-digitaleditions.com/i/1229406
Over the past year, ISAM has worked to provide scientific engagement for its membership and evolve as a leading scientific organization within aerosols in medicine. This article includes new plans for the Aerosol School and a look at the 2021 Congress. ISAM: 2019 highlights and a preview of 2020 activities Philip J. Kuehl, Andrew Martin and Chantal Darquenne The ISAM Journal Underlying all of ISAM's activities is the presentation and publication of cutting-edge scientific research. e official journal of ISAM is the Journal of Aerosol Medicine and Pul- monary Drug Delivery. JAMPDD focuses on pulmonary drug deliv- ery, advances in aerosol medi- cine and formulation and toxic effects of inhaled aerosols. Over the past year, the impact factor for JAMPDD has risen to 2.866 and the journal has seen a 51% increase in manuscript downloads. 2020 Activities Looking further into 2020, ISAM is excited to announce a one-day symposium prior to the American oracic Society (ATS) on May 15, 2020 in Philadelphia (https:// www.isam.org/2020Symposium). e organizing committee has created a program that includes nanotechnology therapies for the lung, e-cigarettes, US require- ments for generic orally inhaled drug products, gene therapy delivery to the respiratory tract and pre-clinical models of lung disease. For anyone attending ATS, this symposium will pro- vide an additional venue for novel scientific presentations. Registra- tion is open on the symposium webpage. ISAM also welcomes sponsors for this event, at the fol- lowing link: https://www.isam. org/2020SymposiumSupport. Additionally, on May 16, 2020, ISAM will host its 6th pre-conference ISAM/ATS ses- e International Society for Aerosols in Medicine (ISAM, www.isam.org) is a scientific orga- nization with a mission to pro- mote and advance aerosol science internationally, focused on health effects of inhaled aerosols, includ- ing inhaled drug delivery for pre- vention and treatment of human diseases. Over the past year, ISAM has worked to provide scientific engagement for its membership and evolve as a leading scientific organization within aerosols in medicine. Some of the most excit- ing events over the past year are highlighted below. The 22nd Congress e biannual ISAM Congress was held in Montreux, Switzerland on May 25-29, 2019. e congress attracted more than 230 interna- tional attendees, including clini- cians, respiratory health care pro- fessionals, aerosol engineers, for- mulation scientists and regulatory representatives. e pre-congress workshops, networking groups and nine scientific sessions were highlights of the 2019 program. In response to its membership and strong leadership commit- ment, a new networking group was organized at the congress: the Women in Aerosol Research's networking group. is network- ing group will engage in activities designed to increase the engage- ment and retention of women in ISAM. e new ISAM board was also initiated during the congress (https://www.isam.org/board). The Aerosol School In October 2019, the Aero- sol School (http://aerosolschool. com/) was presented by St. Joseph's Healthcare, McMaster University and ISAM at the Firestone Re- search Aerosol Laboratory. e school is a hands-on, three-day course offering participants ex- pert information and training in the field of medical aerosols. e course was hosted for the final time by its founder, Professor Myrna Dolovich. After 11 years, the 2020 Aerosol School will be moving to Edmonton, Alberta, Canada and be hosted by Andrew Martin, War- ren Finlay and Reinhard Vehring. Registration is now open on the Aerosol School website (https:// www.isam.org/aerosolschool) and space is limited. So sign up early to save your place and stay tuned to the ISAM and Aerosol School websites for more details. ERS participation As a part of the 2019 European Respiratory Society (ERS) meet- ing in Madrid, Spain, ISAM was present at the World Village and hosted a joint session on "Recent Clinical Advances in Inhalation erapy." e session included a pro/con debate on the role of government in patient utilization of low global warming potential inhalers, and presentations on pediatric disease and non-cystic fibrosis bronchiectasis. ISAM is already planning its participa- tion in the 2020 ERS Congress in Vienna in September 2020. 6 April 2020 Inhalation organizations Cross-industry